SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk | Citedby Results | Cancer Discovery | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk

Cancer Discov (2022) 12 (9): 2158–2179.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Histone lysine methyltransferase SMYD3 promotes oral squamous cell carcinoma tumorigenesis via H3K4me3-mediated HMGA2 transcription

Zongcheng Yang
Fen Liu
Zongkai Li
Nianping Liu
Xinfeng Yao
Yu Zhou
Liyu Zhang
Pan Jiang
Honghong Liu
Lingming Kong
Chuandong Lang
Xin Xu
Jihui Jia
Takahito Nakajima
Wenchao Gu
Lixin Zheng
Zhihong Zhang

Clinical Epigenetics (2023) 15 (1)

RNF113A targeted by miR-197 promotes proliferation and inhibits autophagy via CXCR4/CXCL12/AKT/ERK/Beclin1 axis in cervical cancer

Qingwei Zhang
Jiayu Song
Leijia Cao
Mingzhen Sun
Tenghan Xu
Shaozhe Yang
Suhong Li
Huifen Wang
Xiuhong Fu

Experimental Cell Research (2023) 428 (1): 113632.

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer

Sabeen Ikram
Apurv Rege
Maraki Y. Negesse
Alexandre G. Casanova
Nicolas Reynoird
Erin M. Green

Science Advances (2023) 9 (46)